Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
LT-002 (LeadingTac) in Dermatitis, Atopic: NCT06931990 Clinical Landscape Report 2026
16 October 2026
NCT06931990 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
TRB-061 in Moderate Atopic Dermatitis: NCT06934252 Clinical Landscape Report 2026
16 October 2026
NCT06934252 clinical landscape for Moderate Atopic Dermatitis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Icotrokinra Hydrochloride in Plaque psoriasis: NCT06934226 Clinical Landscape Report 2026
16 October 2026
NCT06934226 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Lenalidomide in Multiple Myeloma: NCT06931704 Clinical Landscape Report 2026
16 October 2026
NCT06931704 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tocilizumab in Refractory Multiple Myeloma: NCT06934044 Clinical Landscape Report 2026
16 October 2026
NCT06934044 clinical landscape for Refractory Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Semaglutide (Novo Nordisk) in Obesity: NCT06937060 Clinical Landscape Report 2026
16 October 2026
NCT06937060 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ZGGS18 in Hepatocellular Carcinoma: NCT06938880 Clinical Landscape Report 2026
16 October 2026
NCT06938880 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cadonilimab in Advanced Colorectal Adenocarcinoma: NCT06940921 Clinical Landscape Report 2026
16 October 2026
NCT06940921 clinical landscape for Advanced Colorectal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…
9 min read
Volrustomig in Locally Advanced Cervical Carcinoma: NCT06943833 Clinical Landscape Report 2026
16 October 2026
NCT06943833 clinical landscape for Locally Advanced Cervical Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white s…
9 min read
Etoposide in Seminoma: NCT06937866 Clinical Landscape Report 2026
16 October 2026
NCT06937866 clinical landscape for Seminoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Dasatinib in Recurrent Multiple Myeloma: NCT06940297 Clinical Landscape Report 2026
16 October 2026
NCT06940297 clinical landscape for Recurrent Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Paclitaxel in Recurrent Cervical Cancer: NCT06942416 Clinical Landscape Report 2026
16 October 2026
NCT06942416 clinical landscape for Recurrent Cervical Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.